A European, non-interventional, multicentre, registry-based post-authorisation safety study to evaluate the long-term safety of Loargys treatment in arginase 1 deficiency patients in standard clinical care First published 07/07/2025 Last updated 07/07/2025 EU PAS number:EUPAS1000000555 Study Planned